Hybrid closed-loop systems to be evaluated within the Orderly introduction framework in Sweden

On September 20, 2024, the Swedish Medical Technologies Product (MTP) Council announced the launch of the national evaluation of hybrid closed-loop systems for adults with type 1 diabetes within the Orderly introduction framework and commissioned the Dental and Pharmaceutical Benefits Agency (TLV) to perform a health economic evaluation. 

The Orderly introduction framework supports the national adoption of novel technologies via a staged process, including horizon scanning, selection of the method for evaluation, the decision on national collaboration, health economic evaluation by the TLV, and recommendations by the MTP Council to regions regarding the implementation of the technology and criteria for use.

TLV is starting a preliminary study to determine how the health economic evaluation should be carried out for this product group. A preliminary study is planned to be completed by the end of 2024, and then, the health economic evaluation can start.

See the full details in Swedish here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.